You searched for "refraction"
Risk factors identified for glaucoma progression in paediatric glaucoma suspects
A retrospective case review was conducted of children (<18 years) identified as being glaucoma suspects using common clinical criteria or the Childhood Glaucoma Research Network definition. Exclusion criteria included penetrating ocular trauma, treated ocular hypertension / glaucoma and use of...
Comparison of structural and functional features in primary angle closure and open-angle glaucoma
In this large cross-sectional study, differences in structural and functional damage were assessed among patients with primary open-angle glaucoma (POAG) and primary angle closure glaucoma (PACG) with optical coherence tomography and reliable visual field testing. Two-hundred and eighty-three patients with...
Retinal Pharmacotherapeutics (Developments in Ophthalmology)
Retinal Pharmacotherapeutics is volume 55 in the ‘Developments in Ophthalmology’ series released by Karger. As the name of the series suggests it aims to explore current and future developments in retinal therapeutics. The book itself is split into six main...Quantum imaging research could improve retinal scans
New EU-funded feasibility project is testing a quantum approach that could reveal finer detail in the eye than ever before. A European research consortium is exploring a new quantum imaging technique that could one day help clinicians see the earliest...Post-stroke visual impairment: how big is the problem, how do we identify it, what we can do about it, and why does it matter?
In the UK, 100,000 new strokes occur each year, with 1.3 million stroke survivors [1]. This article will focus on post-stroke visual impairment, discussing topics of how common it is, how it can be detected, possible management options and how...RNIB welcomes new magnifier coming to a Google Pixel smartphone
RNIB welcomes new magnifier in-your-pocket-feature coming to a Google Pixel smartphone near you.Broadening of treatment options for potentially blinding retinal conditions
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...
